Clinical Trials Browser

Phase 1 × Breast Neoplasms × alfatide II × Clear all

NCT02582801 2019-09-27

Clinical Research of 18F-Alfatide Ⅱ PET/CT in Breast Cancer

Phase 1 Terminated

Breast Neoplasms